Abstract
A particular form of vitiligo of clinically inflammatory vitiligo has been reported as “inflammatory vitiligo with raised borders” or marginal vitiligo and is associated with lichenoid infiltrates in the margins of progressing lesions. In pigmented progressing borders of common vitiligo/NSV and SV, similar features of lesser intensity have been demonstrated suggesting that most subtypes of vitiligo belong to the spectrum of a clinically silent chronic inflammatory skin disorder responsible for melanocyte loss. Clinically inflammatory vitiligo (CIV) has been sometimes associated with infectious or inflammatory diseases. Other rare variants considered in this chapter include follicular vitiligo, vitiligo/leukoderma guttata, and hypopigmented vitiligo/vitiligo minor. For both CIV and hypopigmented vitiligo, biopsies (sometimes repeated) are needed to establish a firm diagnosis, in particular to exclude cutaneous T-cell lymphoma, a major differential diagnosis.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Taïeb A, Picardo M, VETF Members. The definition and assessment of vitiligo: a consensus report of the Vitiligo European Task Force. Pigment Cell Res. 2007;20:27–35.
Buckley W, Lobitz W. Vitiligo with raised inflammatory border. Arch Derm Syph. 1953;67:316–20.
Garb J, Wise F. Vitiligo with raised borders. Arch Derm Syphilol. 1948;58:149–53.
Wise F. Leukoderma with inflammatory borders. Arch Derm Syph. 1942;45:218–9.
Duvic M, Rapini R, Hoots WK, et al. Human immunodeficiency virus-associated vitiligo: expression of autoimmunity with immunodeficiency? J Am Acad Dermatol. 1987;17:656–62.
Grandhe NP, Dogra S, Kumar B. Spontaneous repigmentation of vitiligo in an untreated HIV-positive patient. J Eur Acad Dermatol Venereol. 2006;20:234–5.
Niamba P, Traoré A, Taieb A. Vitiligo sur peau noire associée au VIH et repigmentation lors du traitement antiretroviral. Ann Dermatol Venereol. 2007;134:272–6.
Tsuboi H, Yonemoto K, Katsuoka K. Vitiligo with inflammatory raised borders with hepatitis C virus infection. J Dermatol. 2006;33:577–8.
Weisberg EL, Le LQ, Cohen JB. A case of simultaneously occurring lichen sclerosus and segmental vitiligo: connecting the underlying autoimmune pathogenesis. Int J Dermatol. 2008;47:1053–5.
Sugita K, Izu K, Tokura Y. Vitiligo with inflammatory raised borders, associated with atopic dermatitis. Clin Exp Dermatol. 2006;31:80–2.
Tsuruta D, Hamada T, Teramae H, et al. Inflammatory vitiligo in Vogt-Koyanagi-Harada disease. J Am Acad Dermatol. 2001;44:129–31.
Wong SS, Ng SK, Lee HM. Vogt-Koyanagi-Harada Disease: extensive vitiligo with prodromal generalized erythroderma. Dermatology. 1999;198:65–8.
Gunasekera N, Murphy GF, Sheth VM. Repigmentation of extensive inflammatory vitiligo with raised borders using early and aggressive treatment. Dermatology. 2015;230(1):11–5.
Michaëlsson G. Vitiligo with raised borders. Report of two cases. Acta Derm Venereol. 1968;48:158–61.
Ortonne JP, Baran R, Civatte J. Vitiligo with an inflammatory border. A propos of 2 cases with review of the literature (18 cases). Ann Dermatol Venereol. 1979;106:613–5.
Petit T, Cribier B, Bagot M, Wechsler J. Inflammatory vitiligo-like macules that simulate hypopigmented mycosis fungoides. Eur J Dermatol. 2003;17:410–2.
Swick BL, Walling HW. Depigmented patches with an annular inflammatory border. Clin Exp Dermatol. 2008;33:671–2.
Shin J, Lee JS, Kim MR, Kim do Y, Hann SK, Oh SH. New suggestive clue to the mechanism of vitiligo: inflammatory vitiligo showing prominent leukocytoclasis at the erythematous rim. J Dermatol. 2013;40(6):488–90.
Trikha R, McCowan N, Brodell R. Marginal vitiligo: an unusual depigmenting disorder. Dermatol Online J. 2014;21(3):pii: 13030.
Yagi H, Tokura Y, Furukawa Y, Takigawa M. Vitiligo with raised inflammatory borders: involvement of T cell immunity and keratinocytes expressing MHC class II and ICAM-1 molecules. Eur J Dermatol. 1997;7:19–22.
Tanioka M, Takahashi K, Miyachi YI. Narrowband ultraviolet B phototherapy for inflammatory vitiligo with raised borders associated with Sjögren’s syndrome. Clin Exp Dermatol. 2009;34(3):418–20.
Annessi G, Paradisi M, Angelo C, et al. Annular lichenoid dermatitis of youth. J Am Acad Dermatol. 2003;49:1029–36.
Attili VR, Attili SK. Lichenoid inflammation in vitiligo-a clinical and histopathologic review of 210 cases. Int J Dermatol. 2008;47:663–9.
Hann SK, Park YK, Lee KG, et al. Epidermal changes in active vitiligo. J Dermatol. 1992;19:217–22.
Sharquie KE, Mehenna SH, Naji AA, Al-Azzawi H. Inflammatory changes in vitiligo: stage I and II depigmentation. Am J Dermatopathol. 2004;26:108–12.
Attili VR, Attili SK. Segmental and generalized vitiligo: both forms demonstrate inflammatory histopathological features and clinical mosaicism. Indian J Dermatol. 2013;58(6):433–8.
Ezzedine K, Amazan E, Seneschal J, Cario-André M, Léauté-Labrèze C, Vergier B, Boralevi F, Taieb A. Follicular vitiligo: a new form of vitiligo. Pigment Cell Melanoma Res. 2012a;25(4):527–9.
Ezzedine K, Amazan E, Séneschal J, Cario-André M, Léauté-Labrèze C, Vergier B, Boralevi F, Taieb A. Follicular vitiligo: a new form of vitiligo. Pigment Cell Melanoma Res. 2012b;25:527–9.
Gan EY, Cario-André M, Pain C, Goussot JF, Taïeb A, Seneschal J, Ezzedine K. Follicular vitiligo: a report of 8 cases. J Am Acad Dermatol. 2016;74(6):1178–84.
Ezzedine K, Mahé A, van Geel N, Cardot-Leccia N, Gauthier Y, Descamps V, Al Issa A, Ly F, Chosidow O, Taïeb A, Passeron T. Hypochromic vitiligo: delineation of a new entity. Br J Dermatol. 2015;172(3):716–21.
Gameiro A, Gouveia M, Tellechea Ó, Moreno A. Childhood hypopigmented mycosis fungoides: a commonly delayed diagnosis. BMJ Case Rep. 2014;2014:pii: bcr2014208306.
Ranawaka RR, Abeygunasekara PH, de Silva MV. Hypopigmented mycosis fungoides in type v skin: a report of 5 cases. Case Rep Dermatol Med. 2011;2011:190572.
Soro LA, Gust AJ, Purcell SM. Inflammatory vitiligo versus hypopigmented mycosis fungoides in a 58-year-old Indian female. Indian Dermatol Online J. 2013;4(4):321–5.
Tolkachjov SN, Comfere NI. Hypopigmented mycosis fungoides: a clinical mimicker of vitiligo. J Drugs Dermatol. 2015;14(2):193–4.
Falabella R, Escobar CE, Carrascal E, Arroyave JA. Leukoderma punctata. J Am Acad Dermatol. 1988;18(3):485–94.
Loquai C, Metze D, Nashan D, Luger TA, Böhm M. Confetti-like lesions with hyperkeratosis: a novel ultraviolet-induced hypomelanotic disorder? Br J Dermatol. 2005;153:190–3.
Verma S, Joshi R. Amyloidosis cutis dyschromica: a rare reticulate pigmentary dermatosis. Indian J Dermatol. 2015;60:385–7.
Taïeb A. Vitiligo as an inflammatory skin disorder: a therapeutic perspective. Pigment Cell Melanoma Res. 2012;25(1):9–13.
Levandowski CB, Mailloux CM, Ferrara TM, Gowan K, Ben S, Jin Y, McFann KK, Holland PJ, Fain PR, Dinarello CA, Spritz RA. NLRP1 haplotypes associated with vitiligo and autoimmunity increase interleukin-1β processing via the NLRP1 inflammasome. Proc Natl Acad Sci. 2013;110(8):2952–6.
Marie J, Kovacs D, Pain C, Jouary T, Cota C, Vergier B, Picardo M, Taieb A, Ezzedine K, Cario-André M. Inflammasome activation and vitiligo/nonsegmental vitiligo progression. Br J Dermatol. 2014;170(4):816–23.
Mosenson JA, Zloza A, Nieland JD, Garrett-Mayer E, Eby JM, Huelsmann EJ, Kumar P, Denman CJ, Lacek AT, Kohlhapp FJ, Alamiri A, Hughes T, Bines SD, Kaufman HL, Overbeck A, Mehrotra S, Hernandez C, Nishimura MI, Guevara-Patino JA, Le Poole IC. Mutant HSP70 reverses autoimmune depigmentation in vitiligo. Sci Transl Med. 2013;5(174):174ra28.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Taïeb, A., Ezzedine, K., Seneschal, J., Attili, R. (2019). Clinically Inflammatory Vitiligo and Rare Variants. In: Picardo, M., Taïeb, A. (eds) Vitiligo. Springer, Cham. https://doi.org/10.1007/978-3-319-62960-5_8
Download citation
DOI: https://doi.org/10.1007/978-3-319-62960-5_8
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-62958-2
Online ISBN: 978-3-319-62960-5
eBook Packages: MedicineMedicine (R0)